Thalidomide in the treatment of chronic discoid lupus erythematosus;Lupus érythémateux chronique: Traitement par thalidomide

Annales de Dermatologie et de Venereologie

Volumn 132, Issue 11 I, 2005, Pages 853-856

  Brocard, A ^a   Barbarot, S ^a   Milpied, B ^a   Stalder, J F ^a  

^a CLINIQUE DERMATOLOGIQUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

THALIDOMIDE;

ADULT; ARTICLE; ASTHENIA; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; FOLLOW UP; HUMAN; IMMUNOFLUORESCENCE TEST; MAINTENANCE DRUG DOSE; PARESTHESIA; PATIENT SELECTION; PRESCRIPTION; RETROSPECTIVE STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS; WEIGHT GAIN;

EID: 29844435120     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0151-9638(05)79503-x     Document Type: Article

References (12)

1. Knop J, Bonsmann G, Happle R, Ludolph A, Matz DR, Mifsud EJ, et al. Thalidomide in the treatment of 60 cases of chronic discoid lupus erythematosus. Br J Dermatol 1983;108:461-6.
2. Warren KJ, Nopper AJ, Crosby DL. Thalidomide for recalcitrant discoid lesions in a patient with systemic lupus erythematosus. J Am Acad Dermatol 1998;39:293-5.
3. Hamuryudan V, Mat C, Saip S, Ozyazgan Y, Siva A, Yurdakul S, et al. Thalidomide in the treatment of the mucocutaneous lesions of Behcet's syndrom: a randomised, double-blind, placebo controlled trial. Ann Intern Med 1998;128:443-59.
4. Revuz J, Guillaume JC, Janier M, Hans P, Marchand C, Souteyrand P, et al. Crossover study of thalidomide versus placebo in severe recurrent aphthous stomatis. Arch Dermatol 1990;126:923-7.
5. Laffite E, Revuz J. Thalidomide. Ann Dermatol 2000;127:603-13.
6. Karim MY, Ruiz-Irastorza G, Khamashta MA, Hughes GR. Update on therapy-thalidomide in the treatment of lupus. Lupus 2001;10:188-92.
7. Ordi J, Cortes F, Martinez N, Mauri M, De Torres I, Vilardell M. Thalidomide induces amenorrhea in patients with lupus disease. Arthritis Rheum 1998;41:2273-5.
8. Stevens R, Andujar C, Edwards C, Ames PR, Barwick AR, Khamashta MA, et al. Thalidomide in the treatment of the cutaneous manifestations of lupus erythematosus: experience in sixteen consecutive patients. Br J Rheumatol 1997;36:353-9.
9. Housman TS, Jorizzo JL, McCarty MA, Grummer SE, Fleischer AB, Sutej PC. Low-dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus. Arch Dermatol 2003;139:50-4.
10. Ordi-Ros J, Cortes F, Cucurull E, Mauri M, Bujan S, Vilardell M. Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy. J Rheumatol 2000;27:1429-33.
11. Kyriakis KP, Kontochristopoulos GJ, Panteleos DN. Experience with low-dose thalidomide therapy in chronic discoid lupus erythematosus. Int J Dermatol 2000;39:218-22.
12. Sato EI, Assis LS, Lourenzi VP, Andrade LE. Long-term thalidomide use in refractory cutaneous lesions of systemic lupus erythematosus. Rev Assoc Med Bras 1998;44:289-93.